Aldeyra Therapeutics Navigates Market Fluctuations Amid Focus on Ocular Disease Treatments
Aldeyra Therapeutics, a biotech company focused on treating ocular conditions, has seen significant market fluctuations, but remains committed to innovation and patient care.
2 minutes to read